News
CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer parallel scientific advice to pharmaceutical companies.
Through this new initiative, participating pharmaceutical companies will receive advice simultaneously from CADTH and NICE to facilitate evidence generation for ...
CADTH is currently seeking individuals with diverse experiences with the Canadian health care system for our Patient and Community Advisory Committee.
This newly established committee will provide CADTH with advice on issues relevant to CADTH’s mandate, from the perspectives of those using the Canadian health care system.
We encourage all those ...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Kynmobi
Generic name
apomorphine hydrochloride
Manufacturer
Sunovion Pharmaceuticals Canada Inc.
Indication(s)
Parkinson’s Disease
Project Number
SR0604-000
Call for patient input
2019-01-25
Patient input deadline
2019-03-18
Submit patient input
Submit
Register...
CADTH has received the following notice(s) of pending drug submission(s).
Crysvita
Brand name
Crysvita
Generic name
burosumab
Manufacturer
Kyowa Kirin Limited
Indication(s)
Treatment of X-Linked Hypophosphatemia
Project Number
SR0602-000
Call for patient input
2019-01-24
Patient input deadline
2019-03-15
Submit patient input
Submit
Register as ...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
TBC
Generic name
dolutegravir / lamivudine
Manufacturer
ViiV Healthcare ULC
Indication(s)
HIV-1 infection
Project Number
SR0601-000
Call for patient input
2019-01-23
Patient input deadline
2019-03-14
Submit patient input
Submit
Register as Clinical Expert
Regis...
